Date | Return on Assets (ROA) | Return on Equity (ROE) | Return on Capital Employed (ROCE) | Interest Coverage Ratio |
---|
CEO | Mr. Pranav Jayesh Choksi |
IPO Date | Oct. 19, 2004 |
Location | India |
Headquarters | SM House |
Employees | 1,491 |
Sector | Consumers Staples |
Industries |
Gufic Biosciences Limited engages in manufacture and marketing of active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac, infertility, antiviral, and proton-pump inhibitor segments. In addition, it offers spark, criti care, and ferticare pharmaceutical products; and herbal and personal care products. The company supplies its products to hospital chains and medical facilities. It also exports its products to more than 20 countries. The company was founded in 1970 and is based in Mumbai, India.
Past 5 years
USD 2.10
USD 2.88
USD 28.13
USD 4.09
USD 3.23
StockViz Staff
February 2, 2025
Any question? Send us an email